scispace - formally typeset
J

Jeong-In Baek

Researcher at Daegu Haany University

Publications -  32
Citations -  608

Jeong-In Baek is an academic researcher from Daegu Haany University. The author has contributed to research in topics: Hearing loss & Ototoxicity. The author has an hindex of 14, co-authored 28 publications receiving 476 citations. Previous affiliations of Jeong-In Baek include UPRRP College of Natural Sciences & Medical University of South Carolina.

Papers
More filters
Journal ArticleDOI

Targeted massive parallel sequencing: the effective detection of novel causative mutations associated with hearing loss in small families

TL;DR: This report is the first documenting the effective use of an NGS technique to detect pathogenic mutations that underlie hearing loss in an East Asian population.
Journal ArticleDOI

Effective PEI-mediated delivery of CRISPR-Cas9 complex for targeted gene therapy.

TL;DR: It is demonstrated that BPEI-25K is a promising non-viral vector to deliver the CRISPR/Cas9 system in vitro to mediate targeted gene therapy, and these findings contribute to an understanding of CRISpr/ Cas9 delivery that may enable development of successful in vivo techniques.
Journal ArticleDOI

Evidence for a founder mutation causing DFNA5 hearing loss in East Asians.

TL;DR: A Korean family with autosomal dominant, progressive and sensorineural hearing loss was ascertained and linkage analysis revealed linkage to the DFNA5 locus on chromosome 7, suggesting that the 3-bp deletion is derived from a single origin in these families.
Journal ArticleDOI

Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity

TL;DR: Alpha-lipoic acid contributes to protecting mitochondrial function by preventing ROS accumulation and inhibiting apoptotic cell death and post-treatment with ALA consistently showed an almost equal restorative effect to pretreatment, in vitro and in vivo, supporting the possible use of ALA as a therapeutic agent for cisplatin-induced ototoxicity.
Journal ArticleDOI

Therapeutic potential of the mitochondria-targeted antioxidant MitoQ in mitochondrial-ROS induced sensorineural hearing loss caused by Idh2 deficiency

TL;DR: It is identified that IDH2 is indispensable for the functional maintenance and survival of hair cells and SGNs and suggests that Idh2−/− mice could be a valuable animal model for evaluating the therapeutic effects of various antioxidant candidates to overcome ROS-induced hearing loss.